Zota Health Care approves September 2025 quarterly and half-year results

Related Party TransactionsResults View source PDF Explain this filing

ZOTA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.3%Reaction day

₹1525.00

prior close

₹1543.50

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.0%+2.3% vs market

Pharmaceuticals peers, median of 153sector+0.2%+3.0% vs sector

On the reaction day the stock moved 2.3 pts more than Nifty Microcap 250 and 3.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.0

10m

-1.1

15m

-0.8

30m

+0.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.3+1.0+2.3+0.2+3.0

Next day

+4.6+2.0+2.5+0.9+3.7

+0.9+1.6-0.6+0.5+0.4

+0.3+1.2-0.9+0.3+0.1

+3.0+1.6+1.4+0.3+2.7

+2.4+1.9+0.5+0.1+2.3

+1.8+2.1-0.4+0.6+1.1

15d

+0.1+1.0-1.0-1.0+1.1

+9.6+0.2+9.4-2.1+11.6

+1.6-3.1+4.7-4.2+5.9

-17.0-10.9-6.1-11.9-5.2

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 153Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board approved unaudited standalone and consolidated results for the quarter and half year ended September 30, 2025. No material issue was raised in the review. Subsidiaries reported quarterly revenue of Rs 6,432.52 lakh and net losses of Rs 2,666.72 lakh for the quarter and Rs 4,628.24 lakh for the half year. Warrants were converted into shares, and a further 9.98% in EHBCPL was bought from its director, raising the stake to 65.98%.

Likely market impact

No material review concern, but losses and conversions may weigh on sentiment; EHBCPL shares were bought from its director in a related-party deal.